Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mindset Pharma Inc (CSE: MSET )

0.7400 UNCHANGED
Last Price Updated: 12:33 PM EDT, Oct 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7400
Bid (Size) 0.5400 (7,000)
Ask (Size) 0.7500 (111,000)
Prev. Close 0.7400
Today's Range 0.7400 - 0.7400
52wk Range 0.2650 - 0.7500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
PharmAla will be the exclusive global reseller of Mindset’s cGMP psilocybin to appropriately licensed clinical researchers 
From PharmAla Biotech
Via GlobeNewswire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-1.33%
-1.33%
1 Year
+120.90%
+120.90%

More News

Read More
The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma
From The Market Herald
Via AccessWire
Mindset Announces Participation at Upcoming Events in June 2021
Via Newsfile
Topics Cannabis
Exposures Cannabis
Mindset Pharma Invited to Present at Canaccord Genuity 41st Annual Growth Conference
Via Newsfile
Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds
Via Newsfile
Mindset Pharma Engages KCSA Strategic Communications to Provide Investor Relations Services
Via Newsfile
Mindset Pharma Invited to Present at H.C. Wainwright "Psychedelics in Psychiatry and Beyond" Virtual Conference
Via Newsfile
Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Entire New Drug Program Portfolio
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.